Legis Daily

Ensuring Access to COVID-19 Preventive Care Act of 2020

USA116th CongressHR-6231| House 
| Updated: 3/12/2020
Larry Bucshon

Larry Bucshon

Republican Representative

Indiana

Cosponsors (1)
Janice D. Schakowsky (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Ensuring Access to COVID-19 Preventive Care Act of 2020 This bill requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020. The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 12, 2020
Introduced in House
Mar 12, 2020
Referred to the House Committee on Energy and Commerce.
  • March 12, 2020
    Introduced in House


  • March 12, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Advisory bodiesCardiovascular and respiratory healthEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methods

Ensuring Access to COVID-19 Preventive Care Act of 2020

USA116th CongressHR-6231| House 
| Updated: 3/12/2020
Ensuring Access to COVID-19 Preventive Care Act of 2020 This bill requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020. The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 12, 2020
Introduced in House
Mar 12, 2020
Referred to the House Committee on Energy and Commerce.
  • March 12, 2020
    Introduced in House


  • March 12, 2020
    Referred to the House Committee on Energy and Commerce.
Larry Bucshon

Larry Bucshon

Republican Representative

Indiana

Cosponsors (1)
Janice D. Schakowsky (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesCardiovascular and respiratory healthEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methods